Novavax, Inc. NVAX

NAS: NVAX | ISIN: US6700024010 8/06/2026

8,620 USD (-9,17%)

(-9,17%) 8/06/2026

Grafiek Novavax, Inc.

Grafiek Novavax, Inc.

1 dag1d -9,17%
1 week1w -15,57%
1 maand1m -9,26%
3 maanden3m -18,29%
6 maanden6m 29,43%
1 jaar1j 16,33%
5 jaar5j -95,89%

Novavax, Inc. in het nieuws

Toon enkel gratis nieuws

1 juni 2026 · Novavax to Participate in 2026 Jefferies Global Healthcare Conference · Persbericht

7 mei 2026 · Novavax to Participate in BofA Securities 2026 Health Care Conference · Persbericht

6 mei 2026 · Novavax Reports First Quarter 2026 Financial Results and Operational Highlights · Persbericht

29 april 2026 · Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 · Persbericht

30 maart 2026 · Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development · Persbericht

26 februari 2026 · Novavax to Participate in Upcoming Investor Conferences · Persbericht

26 februari 2026 · Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights · Persbericht

19 februari 2026 · Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 · Persbericht

20 januari 2026 · Novavax Announces Entering into a License Agreement with Pfizer · Persbericht

7 januari 2026 · Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Novavax, Inc.

Gezondheidstechnologie

Productie van biologische producten

Website: www.novavax.com

Hoofdzetel: Gaithersburg, Maryland Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe